The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany

PURPOSE: The aim of this cross-sectional health care study (use of bisphosphonates in primary tumors of the mammae, EBisMa) is to determine how often bisphosphonate medication is used in patients with non-metastatic primary breast cancer treatment, but who do not suffer from osteoporosis. Furthermor...

Descripción completa

Detalles Bibliográficos
Autores principales: Fick, Eva-Maria, Katalinic, Alexander, Waldmann, Annika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614212/
https://www.ncbi.nlm.nih.gov/pubmed/25672584
http://dx.doi.org/10.4143/crt.2014.099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614212/
https://www.ncbi.nlm.nih.gov/pubmed/25672584
http://dx.doi.org/10.4143/crt.2014.099

Ejemplares similares